| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9850 |
| Human Intestinal Absorption | HIA+ | 0.9908 |
| Caco-2 Permeability | Caco2+ | 0.7412 |
| P-glycoprotein Substrate | Substrate | 0.8125 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8842 |
| Inhibitor | 0.8078 |
| Renal Organic Cation Transporter | Inhibitor | 0.6956 |
| Distribution |
| Subcellular localization | Lysosome | 0.7989 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7980 |
| CYP450 2D6 Substrate | Substrate | 0.6737 |
| CYP450 3A4 Substrate | Non-substrate | 0.5092 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7057 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8935 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.9137 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.7763 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9289 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8902 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8893 |
| Inhibitor | 0.8204 |
| AMES Toxicity | Non AMES toxic | 0.7839 |
| Carcinogens | Non-carcinogens | 0.8983 |
| Fish Toxicity | High FHMT | 0.9787 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9934 |
| Honey Bee Toxicity | Low HBT | 0.8156 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.6920 |
| Carcinogenicity (Three-class) | Non-required | 0.7052 |